Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men
Megadott ok: Closed due to lack of funding.
Key facts
- Where
- Mumbai, IndiaSee the 2 sites
Where in India
- Tata Memorial HospitalMumbai, IndiaNo longer taking part
- Udaan TrustMumbai, IndiaNo longer taking part
Trial details
- Who runs it
- AIDS Malignancy Consortium
- Trial code
- NCT04142398
- Record updated
- 2025. június 6.
- Original description
This research trial studies the incidence of human papilloma virus (HPV) infection and HPV-associated disease in screening Indian men who have sex with human immunodeficiency virus (HIV)-positive men. Gathering health information over time from Indian men who have sex with men (MSM) may help doctors determine how many HIV -positive MSM develop new HPV infections and how many HIV-positive MSM have HPV related disease.Read full original descriptionShow less
Investigating Human Papillomavirus (HPV) Infection and HPV-Associated Disease in Indian Men Who Have Sex With Men Who Are HIV-Positive
This research trial studies the incidence of human papilloma virus (HPV) infection and HPV-associated disease in screening Indian men who have sex with human immunodeficiency virus (HIV)-positive men. Gathering health information over time from Indian men who have sex with men (MSM) may help doctors determine how many HIV -positive MSM develop new HPV infections and how many HIV-positive MSM have HPV related disease.
Inclusion: HIV positive, as documented by any licensed HIV test according to the Indian National acquired immune deficiency syndrome (AIDS) Control Organization (NACO) guidelines; Participants report any sex with a man in the past 6 months; Participants must speak Hindi, Marathi, or English; Participants should not have any plans to move out of the area in the next 12 months and commit to attending two additional visits one at 6 months and one at 12 months.
Exclusion: Active drug or alcohol use or dependence, or other impairment that, in the opinion of the site investigator, would interfere with adherence to study requirements; Participants with impairments that, in the opinion of the site investigator, are temporary, will be asked to return another day for enrollment; History of a sex change operation that would preclude collection of penile or scrotal specimens; Inability to provide informed consent.